Matching articles for "Mifeprex"
Issue 1679 · June 26, 2023 Free
In Brief: Alternatives to Mifepristone for Medication Abortion

The possibility that use of mifepristone ( Mifeprex , and generics) may be restricted has led to questions about alternatives for medication abortion.

Med Lett Drugs Ther. 2023 Jun 26; 65(1679):102-3 doi:10.58347/tml.2023.1679d
The possibility that use of mifepristone ( Mifeprex , and generics) may be restricted has led to questions about alternatives for medication abortion.
Issue 1670 · February 20, 2023 Free
In Brief: Expanded Access to Mifepristone

First approved in 2000 for termination of pregnancies of ≤49 days' gestation, the indication for the oral antiprogestin mifepristone ( Mifeprex , and generics) was expanded in 2016 to include pregnancies of…

Med Lett Drugs Ther. 2023 Feb 20; 65(1670):31 doi:10.58347/tml.2023.1670c
First approved in 2000 for termination of pregnancies of ≤49 days' gestation, the indication for the oral antiprogestin mifepristone ( Mifeprex , and generics) was expanded in 2016 to include pregnancies of up to 10 weeks' gestation. A single 200-mg oral dose of mifepristone followed 24-48 hours later by a single 800-mcg buccal dose of the prostaglandin analog misoprostol terminates early intrauterine pregnancies in about 95% of women.
Issue 1642 · January 24, 2022 Free
In Brief: Mifepristone by Mail for Pregnancy Termination

The FDA has removed the requirement that mifepristone ( Mifeprex , and generics), a progestin receptor antagonist approved for use in a regimen with the prostaglandin E1 analog misoprostol ( Cytotec , and…

Med Lett Drugs Ther. 2022 Jan 24; 64(1642):11
The FDA has removed the requirement that mifepristone ( Mifeprex , and generics), a progestin receptor antagonist approved for use in a regimen with the prostaglandin E1 analog misoprostol ( Cytotec , and generics) for medical termination of pregnancy, must be dispensed in person to the patient.
Issue 1493 · April 25, 2016
Mifepristone (Mifeprex) Label Changes

The FDA has approved several significant changes in the labeling of mifepristone ( Mifeprex – Danco), an oral antiprogestin that has been used in the US for more than 15 years for termination of intrauterine…

Med Lett Drugs Ther. 2016 Apr 25; 58(1493):55-6
The FDA has approved several significant changes in the labeling of mifepristone ( Mifeprex – Danco), an oral antiprogestin that has been used in the US for more than 15 years for termination of intrauterine pregnancy. It has generally been used with the prostaglandin analog misoprostol ( Cytotec , and generics).
Issue 1411 · March 4, 2013
Misoprostol for Miscarriage

Misoprostol ( Cytotec , and generics), a prostaglandin E 1 analog FDA-approved for prevention of NSAID-induced gastric ulcers and, when taken with mifepristone (Mifeprex) , for termination of early…

Med Lett Drugs Ther. 2013 Mar 4; 55(1411):19-20
Misoprostol ( Cytotec , and generics), a prostaglandin E 1 analog FDA-approved for prevention of NSAID-induced gastric ulcers and, when taken with mifepristone (Mifeprex) , for termination of early intrauterine pregnancy, has also been used off-label for years for medical management of first-trimester spontaneous abortion (miscarriage).
Issue 1091 · October 30, 2000
Mifepristone (RU 486)

Mifepristone (RU 486; Mifeprex - Danco), an antiprogestin, has been approved by the FDA for termination of intrauterine pregnancies of 49 days or less. It is generally used with misoprostol ( Cytotec -…

Med Lett Drugs Ther. 2000 Oct 30; 42(1091):101-2
Mifepristone (RU 486; Mifeprex - Danco), an antiprogestin, has been approved by the FDA for termination of intrauterine pregnancies of 49 days or less. It is generally used with misoprostol ( Cytotec - Searle), an E 1 prostaglandin analog marketed in the USA only for prevention of gastric ulcers.